MetaCap

GoodRx (GDRX) vs OneSpan (OSPN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

OneSpan (OSPN) has outperformed GoodRx (GDRX) over the past year, gaining 82.8% versus a gain of 7.7%. Over five years, OSPN leads with a +29.7% price change compared with -92.1% for GDRX. GoodRx is the larger company by market cap ($996.1 million vs $808.7 million), about 1.2 times the size.

On valuation, GoodRx trades at a lower forward P/E (8.3x vs 15.9x for OneSpan). OneSpan pays a dividend yielding 2.37%, while GoodRx does not currently pay one. OneSpan converts more of its revenue into profit, with a net margin of 30.0% versus 3.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GDRX+7.75%OSPN+82.82%
+121%+42%-38%
Nov 21, 20251 yearNov 20, 2026
GDRX-92.70%OSPN+18.94%
+46%-28%-102%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GDRX versus OSPN key metrics
MetricGDRXOSPN
Share price$2.92$21.92
Market cap$996.14M$808.73M
1-day change-3.31%-2.88%
YTD return+7.75%+70.72%
1-year return+7.75%+82.82%
5-year return-92.07%+29.70%
P/E ratio (TTM)58.4012.18
Forward P/E8.2915.88
EPS (TTM)$0.05$1.80
Dividend yield0.00%2.37%
Annual dividend$0.00$0.52
Revenue (latest FY)$796.85M$243.18M
Revenue growth (YoY)+0.57%+0.00%
Net income (latest FY)$30.44M$72.90M
Gross margin92.77%73.75%
Operating margin10.98%19.92%
Net margin3.82%29.98%
52-week high$3.89$27.45
52-week low$1.77$10.07
Distance from 52-week high-24.94%-20.15%
Analyst consensusholdnone
Avg. price target upside+35.27%+7.21%
Average volume1.09M668.09K
Shares outstanding107.18M36.89M
Employees697520
SectorTechnologyTechnology
IndustryEDP ServicesEDP Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OSPN has outperformed GDRX by 75.1 percentage points over the past year.
  • GoodRx trades at a higher earnings multiple (58.4x vs 12.2x trailing P/E).
  • OneSpan offers a meaningfully higher dividend yield (2.37% vs 0.00%).
  • OneSpan is more profitable, keeping 30.0 cents of every revenue dollar as net income versus 3.8 cents for GoodRx.

About GoodRx

GDRX stock →

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

Technology · EDP Services · 697 employees

About OneSpan

OSPN stock →

OneSpan Inc., together with its subsidiaries, provides digital solutions for security, authentication, identity, electronic signature, and digital workflow products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. It operates through Cybersecurity and Digital Agreements segments.

Technology · EDP Services · 520 employees

GDRX vs OSPN FAQ

Which is bigger, GoodRx or OneSpan?

GoodRx (GDRX) is larger, with a market capitalization of $996.14M compared with $808.73M for OneSpan (OSPN).

Which stock has performed better over the past year, GDRX or OSPN?

OSPN returned +82.82% over the past 12 months, compared with +7.75% for GDRX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, GDRX or OSPN?

OSPN has the lower trailing P/E at 12.2, versus 58.4 for GDRX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, GoodRx or OneSpan?

OneSpan pays a dividend yielding 2.37%, while GoodRx does not currently pay a regular dividend.

Are GoodRx and OneSpan in the same industry?

Yes. Both are classified in the EDP Services industry within the Technology sector.

More comparisons